vix.ing · top · new · best · stats · spec

Peter Kolkhof

  1. Cardiovascular and kidney outcomes with finerenone in patients with type 2 diabetes and chronic kidney disease: the FIDELITY pooled analysis
    2021/11/01 by Rajiv Agarwal, Gerasimos Filippatos, Bertram Pitt +12 · 28 citations
    Medicine · #Diabetes Treatment and Management #Heart Failure Treatment and Management #Potassium and Related Disorders
  2. 30 YEARS OF THE MINERALOCORTICOID RECEPTOR: Mineralocorticoid receptor antagonists: 60 years of research and development
    2017/06/20 by Peter Kolkhof, Lars Bärfacker · 28 citations
    Medicine · Biochemistry, Genetics and Molecular Biology · #Hormonal Regulation and Hypertension #Adrenal Hormones and Disorders #Ion Transport and Channel Regulation
  3. Finerenone and Cardiovascular Outcomes in Patients With Chronic Kidney Disease and Type 2 Diabetes
    2020/11/17 by Gerasimos Filippatos, Stefan D. Anker, Rajiv Agarwal +10 · 29 citations
    Medicine · Biochemistry, Genetics and Molecular Biology · #Hormonal Regulation and Hypertension #Heart Failure Treatment and Management #Ion Transport and Channel Regulation
  4. Steroidal and non-steroidal mineralocorticoid receptor antagonists in cardiorenal medicine
    2020/09/01 by Rajiv Agarwal, Peter Kolkhof, George L. Bakris +6 · 6 citations
    Biochemistry, Genetics and Molecular Biology · Medicine · #Cardiovascular, Neuropeptides, and Oxidative Stress Research #Hormonal Regulation and Hypertension #Ion Transport and Channel Regulation